<DOC>
	<DOC>NCT01464827</DOC>
	<brief_summary>This is a study of combination direct-acting antiviral agents (DAA) with or without ribavirin (RBV) in patients with chronic Hepatitis C Virus (HCV).</brief_summary>
	<brief_title>ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients</brief_title>
	<detailed_description>A study to evaluate the safety and effectiveness of experimental drugs ABT-450, ABT-267 (also known as ombitasvir), ABT-333 (also known as dasabuvir), ritonavir, and ribavirin in participants with HCV. The study will test the safety and effects of combinations of these drugs in treatments up to 24 weeks.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>Males and females 1870 years old, inclusive Females must be postmenopausal for more than 2 years or surgically sterile or practicing specific forms of birth control Chronic hepatitis C virus (HCV), genotype 1 infection Treatmentnaive OR nullresponders to previous treatment with pegylated interferon (pegIFN) and ribavirin (at least 12 weeks of treatment and failure to achieve a 2 log10 HCV RNA decrease at Week 12) No evidence of liver cirrhosis Significant liver disease with any cause other than HCV as the primary cause Positive hepatitis B surface antigen and antihuman immunodeficiency virus antibody Positive screen for drugs and alcohol Significant sensitivity to any drug Use of contraindicated or prohibited medications within 1 month of dosing Abnormal laboratory tests</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Hepatitis C Genotype 1</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Interferon-Free</keyword>
	<keyword>HCV</keyword>
	<keyword>Chronic Hepatitis C</keyword>
</DOC>